Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics.

The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped.